Anthony S. Fiorino, Chief Executive Officer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 800 shares at $3.84 ($3K) on 2014-09-18, disclosed to the SEC on 2014-09-19.
Open-market purchase of $3k BCLI by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| BCLI | BUY | 2014-10-15 | $2K | — | Filing → |
| BCLI | BUY | 2014-09-16 | $5K | — | Filing → |